Tag Archives: Treatment

FDA Approves Reblozyl (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular Red Blood Cell Transfusions

FDA Approves Reblozyl (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular Red Blood Cell Transfusions Print this page SUMMIT, N.J. & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced the U.S. Food and Drug Administration (FDA) has approved Reblozyl (luspatercept-aamt) for the… Read More »

Allergies: Teenagers needing hospital treatment up 65% in five years

The number of children who received hospital treatment for allergies has increased by 65% across England in the past five years, figures have revealed. In 2013-14, 2,873 teenagers sought treatment whereas in 2017-18 it was 4,743, data from NHS Digital shows. Allergy UK said this could be because this was the age when sufferers started… Read More »

Is There Treatment for Varicose Veins?

What Are Varicose Veins, and What Causes Them? Blood is meant to travel from your heart throughout your body via your veins. These veins have valves that open to let blood flow past and close off behind it. When these valves aren’t working correctly or become weak, blood is then backed up around the vein… Read More »

FDA Approves Aklief (trifarotene) Cream, a New Topical Retinoid for the Treatment of Acne

FDA Approves Aklief (trifarotene) Cream, a New Topical Retinoid for the Treatment of Acne Print this page FORT WORTH, Texas (October 4, 2019) Galderma, a global leader focused on meeting the world’s increasing skin health needs, announced today that the U.S. Food and Drug Administration (FDA) approved Aklief (trifarotene) Cream, 0.005% for the topical treatment… Read More »

First peanut allergy treatment gains backing from FDA advisory panel – Science Magazine

By Jennifer Couzin-FrankelSep. 13, 2019 , 5:15 PM After 8 hours of contentious discussion, an advisory committee to the U.S. Food and Drug Administration (FDA) today endorsed the effectiveness of a first-of-its-kind peanut allergy treatment. By a seven-to-two vote, the panel concluded that the treatment, known as AR101, can reduce allergic reactions from accidental exposure to… Read More »